Article ID Journal Published Year Pages File Type
8715019 Journal of the American Academy of Dermatology 2018 8 Pages PDF
Abstract
Most psoriasis patients who receive tofacitinib can mount satisfactory T-cell-dependent responses to PCV-13 and tetanus vaccines.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Preview
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment
Authors
, , , , , , , , , ,